Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
US8324254B2 · kind B2 · utility
2Cited by
7References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2008 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Jul 25, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula (I) or salts thereof:having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders mediated by S1P1 receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.